product summary
Loading...
company name :
MyBioSource
product type :
antibody
product name :
Forkhead box protein 3
catalog :
MBS540024
quantity :
0.1-0.15 ml WB Contr
price :
290 USD
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
application :
western blot, immunoprecipitation
more info or order :
product information
catalog number :
MBS540024
products type :
Antibody
products full name :
Forkhead box protein 3
products short name :
Forkhead box protein 3
products name syn :
CD80 antigen (CD80) antibodies
other names :
Forkhead box P3
other gene names :
Foxp3
uniprot entry name :
Q53Z59_MOUSE
clonality :
Polyclonal
host :
Rabbit
purity :
Affinity purifed
concentration :
~0.5mg/ml
storage stability :
Shipped at 4 degree C. Store at -20 degree C
tested application :
Western Blot (WB), Immunoprecipitation (IP)
other info1 :
Immunogen: peptide
other info2 :
Preservatives: 0.02% Na3N. Buffer: PO4-buffer/Tris/Glycine, pH 7.4-7.8. PO4-buffer/Tris/Glycine, pH 7.4-7.8
products categories :
Antibodies to targets that regulate Immune response
products description :
Alternate Nomenclature: B-lymphocyte activation antigen B7-1, B7, CD80. The vertebrate immune system has an important self check mechanism that prevents it from destroying the host own immune system and regulatory T cells are part of this regulatory suppressive control by interacting with CD80 and CD86 (1). The cytotoxic T lymphocyte antigen 4 (CTLA4) is a protein that is expressed on regulatory T lymphocytes and is involved in restraining the immune response when needed and in tachyphylaxis and tolerance. The Fox3p-CD4+ (CD25+CD4+) regulatory T cells (Tregs) express transcription factor Foxp3 suppress aberrant immune responses as seen in autoimmune diseases and allergy (2). CD80 is a costimulatory ligand that interacts with CD28 and cytotoxic lymphocyte antigen 4 (CTLA4) in the regulation of T cell response. CD80 along with CD86 expression on antigen presenting cells (APCs) have the ability to augment T cell responses through interactions with CD28 (3) or inhibit T cell responses through interaction with CTLA-4 (4). The CD80/CD86 interaction with CD28/CTLA-4 occurs in the contact area between T cells and APC in parallel with T cell antigen receptor interaction with MHC-peptide complexes and LFA-1 interaction with ICAM-1 (4). The CTLA4 expressed in Fox3p positive tregs is critically required for their in vivo and in vitro suppression which is mediated at least in part by CTLA4 dependent down regulation of CD80 and CD86 in antigen presenting cells. CD80 and CD86 are cell surface markers expressed on human dendritic cells and mature B-lymphocytes and they play a critical role in stimulating T lymphocyte response by their interaction with the ligand CTLA4 and CD28. CD80 and CD86 are up-regulated during the process of dendritic cell maturation and are over expressed in variety of lymphocytic neoplasm (6). CD80 expression is selectively increases in freshly prepared spleen B cells treated with LPS for 9-12 hours and when they are exposed to X-radiation, whereas CD86 is not affected and only slight increase in CD54, major histocompatibility complex class II, CD11a or surface immunoglobulin M was observed (5). CD80/CD86 co-stimulation is important for the immune response to vesicular stomatitis virus, herpes simplex virus and influenza virus. CD80/CD86 serve a a means of adenovirus entry on human dendritic cells and the interaction of CD80/CD86 with CTLA4 is also important in long-term control of murine gammaherpesvirus-68 virus. CD80 provides a regulatory signals for T lymphocytes as a consequence of binding to the CD28 and CTLA4 ligands of T cells. CD80 is a 321 amino acid (39kDa) protein expressed on Treg. The CD80-selective antibodies were generated against peptide form unique region of the CD80 gene that is not present in CD antigen or other cellular proteins. The antigenic sequence was common in rat, mouse but distinct from human CD80 gene. MyBioSource has generated epitope specific anti-CD80 mono-epitope-specific antibodies utilizing cyclic peptide methodology. The Anti-CD80 antibodies have been fully characterized for cross reactivity with other cellular proteins using Western blot analyses. Limited quantities of antigenic blocking peptide and Western blot positive controls in ready-to-use buffer for CD80 are also available. MyBioSource., will conjugate this antibody to fluorophores and to secondary enzymes at a nominal charge. MyBioSource also carry a wide selection of CD ant
ncbi gi num :
123213503
ncbi acc num :
CAM25950
uniprot acc num :
Q53Z59
ncbi mol weight :
47,346 Da
uniprot summary :
Sequence similarities: Contains 1 fork-head DNA-binding domain. SAAS SAAS018122
size :
0.1-0.15 ml WB Control
price :
290 USD
more info or order :
company information
MyBioSource
P.O. Box 153308
San Diego, CA 92195-3308
sales@mybiosource.com
https://www.mybiosource.com
1-888-627-0165
headquarters: USA
MyBioSource, LLC was orginally founded in Vancouver by three enthusiastic scientists who are passionate about providing the world with the best reagents available. Together, they form a company with a big vision known as MyBioSource. MyBioSource is now located in San Diego, California, USA.

"MyBioSource's number 1 vision is to be the world's number 1 quality reagents provider."

Our goal is to provide researchers, scientists and customers alike with a one-stop-shop for all of their reagents needs, whether it is monoclonal antibody, polyclonal antibody, recombinant protein, peptide, etc...

"MyBioSource offers the best products at unbeatable prices."

Please spend a few minutes to browse our online catalogs and see the wide range of products available. We ship our products through our shipping/distribution facility in San Diego, California, USA.

Would you like to receive email and e-newsletter from MyBioSource about new products, special offers and events? Please click here to join our Mailing List!